People | February 15, 2025
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The transaction is expected to result in approximately $175 million to support further development of IMG-007
The CDMO business will be structured into three new business platforms designed to create a unified organization: Integrated Biologics, Advanced Synthesis, and Specialized Modalities
This acquisition positions Suven as a key player in one of the fastest growing segments of the Pharma CDMO landscape
Aims to become India’s leading cancer testing company
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
With the addition of Karsanbhai, the Merck board will consist of 13 members
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
Subscribe To Our Newsletter & Stay Updated
